PubMed Health⌕ Search

PubMed · 10633023

Need for evidence-based practice in prosthodontics.

Abstract

STATEMENT OF PROBLEM: Patients, their insurers, the courts, and the scientific community are demanding more evidence to support the effectiveness of health care strategies. PURPOSE: This article describes evidence-based practice, its origins, and value as a way of addressing the demand for evidence of treatment effectiveness in maxillofacial prosthetics. MATERIAL AND METHODS: A limited review of maxillofacial prosthetics literature was performed using Medline over the years 1966 to 1998. The retrieved articles were classified by methodologic design and assessed for the strength of their evidence. RESULTS: Focused and speedy (but not necessarily comprehensive) literature searching methods are available. Critical appraisal skills are available and needed to assess the quality of evidence in support of a treatment and to maintain clinical skills. CONCLUSION: With appropriate skills and the availability of literature searching hardware and software, evidence-based practice is a powerful means for the practitioner to establish the effectiveness of individual patient treatment, and to prevent the diminution of clinical skills over the course of a career. These skills should be included in training programs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J D Anderson. 2000. Need for evidence-based practice in prosthodontics.. https://doi.org/10.1016/s0022-3913(00)70089-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].

The defining clinical features of acute and transient psychotic disorders (ICD-10: F23) are an acute onset and a duration of psychotic symptoms not exceeding 1-3 months. Previous empirical investigations show that patients with this diagnosis have a favourable prognosis, but also a high risk of relapses (58-77%). The diagnostic stability in the further course of illness seems to be low (34-73%) with a frequent diagnostic change to schizophrenia and affective disorders being observed. As yet, data from controlled clinical trials regarding therapy do not exist. The implications for the treatment of acute and transient psychotic disorders are discussed with this background.

Evidence-Based Medicine↗